HHS · Harte Hanks Inc
$2.18
At close · Jul 29
Market Cap
$16.32M
Shares
7.42M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| David Fisher | CEO | $958,440 |
| David Garrison | CFO | $501,950 |
| Robert Wyman | General Counsel | $403,750 |
| Kirk Davis | CEO | $73,498 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| David Garrison | CFO | $744,303 |
| Kirk Davis | CEO | $706,950 |
| Robert Wyman | General Counsel | $478,003 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Kirk Davis | CEO | $1,439,830 |
| Brian Linscott | CEO | $942,313 |
| Laurilee Kearnes | CFO | $799,341 |
| General Counsel | — | $315,000 |
| Robert Wyman | General Counsel | $315,000 |
| David Garrison | CFO | $150,400 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Brian Linscott | CEO | $1,467,890 |
| Laurilee Kearnes | CFO | $827,947 |
| Robert Wyman | General Counsel | $496,688 |